{"entity":{"type":"insider","cik":"0001296549","url":"/insider/0001296549","json_url":"/insider/0001296549.json","name":"Belldegrun Arie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":20,"first":"2007-03-09","last":"2025-09-16","span_basis":"filed_date"},"name_variants":[{"name":"Belldegrun Arie","source":"filing","n_filings":20,"first_seen":"2007-03-09","last_seen":"2025-09-16"}],"transactions":[{"id":4066224,"accession":"0001193125-25-204935","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-204935","line_url":"/filing/0001193125-25-204935","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"LB PHARMACEUTICALS INC","issuer_ticker":"LBRX","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":null,"owner_name":"Belldegrun Arie; Vida Ventures GP III, L.L.C.; Vida Ventures III, L.P.; Vida Ventures III-A, L.P.; Vida Ventures Management Co. LLC","owner_display_name":"Belldegrun Arie","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":880214.0,"shares_owned_after_display":"880,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-16","scope":"insider","n_lines":2},{"id":2925069,"accession":"0001737287-24-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001737287-24-000042","line_url":"/filing/0001737287-24-000042#line-2","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1724137.0,"shares_display":"1,724,137","price_per_share":2.9,"price_display":"2.90","price_state":"stated","total_value":4999997.3,"total_display":"4,999,997.30","total_whole":"4,999,997","shares_owned_after":1724137.0,"shares_owned_after_display":"1,724,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":6615703,"accession":"0001214659-22-000701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-000701","line_url":"/filing/0001214659-22-000701#line-1","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":155039.0,"shares_display":"155,039","price_per_share":12.6,"price_display":"12.60","price_state":"stated","total_value":1953491.4,"total_display":"1,953,491.40","total_whole":"1,953,491","shares_owned_after":195039.0,"shares_owned_after_display":"195,039","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-12","filed_date":"2022-01-14","scope":"insider"},{"id":2227596,"accession":"0001214659-20-005383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-005383","line_url":"/filing/0001214659-20-005383","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":146382.0,"shares_display":"146,382","price_per_share":47.0,"price_display":"47.00","price_state":"stated","total_value":6879954.0,"total_display":"6,879,954.00","total_whole":"6,879,954","shares_owned_after":1798163.0,"shares_owned_after_display":"1,798,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-04","scope":"insider","n_lines":2},{"id":9270781,"accession":"0001209191-19-009724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-009724","line_url":"/filing/0001209191-19-009724#line-1","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":194445.0,"shares_display":"194,445","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":3500010.0,"total_display":"3,500,010.00","total_whole":"3,500,010","shares_owned_after":1691781.0,"shares_owned_after_display":"1,691,781","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2019-02-13","scope":"insider"},{"id":6156524,"accession":"0001209191-18-055372","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-055372","line_url":"/filing/0001209191-18-055372#line-4","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":630000.0,"total_display":"630,000.00","total_whole":"630,000","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-17","scope":"insider"},{"id":4743571,"accession":"0001209191-17-054193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-054193","line_url":"/filing/0001209191-17-054193#line-2","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26347.0,"shares_display":"26,347","price_per_share":179.6639,"price_display":"179.66","price_state":"stated","total_value":4733604.7733,"total_display":"4,733,604.77","total_whole":"4,733,605","shares_owned_after":109160.0,"shares_owned_after_display":"109,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-25","filed_date":"2017-09-27","scope":"insider"},{"id":4988591,"accession":"0001209191-17-030899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-030899","line_url":"/filing/0001209191-17-030899#line-1","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17000.0,"shares_display":"17,000","price_per_share":68.57,"price_display":"68.57","price_state":"stated","total_value":1165690.0,"total_display":"1,165,690.00","total_whole":"1,165,690","shares_owned_after":85507.0,"shares_owned_after_display":"85,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-09","scope":"insider"},{"id":2257385,"accession":"0001209191-16-156541","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-156541","line_url":"/filing/0001209191-16-156541#line-1","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3493.0,"shares_display":"3,493","price_per_share":50.86,"price_display":"50.86","price_state":"stated","total_value":177653.98,"total_display":"177,653.98","total_whole":"177,654","shares_owned_after":24707.0,"shares_owned_after_display":"24,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-20","filed_date":"2016-12-22","scope":"insider"},{"id":2502416,"accession":"0000914190-16-000741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914190-16-000741","line_url":"/filing/0000914190-16-000741#line-1","is_derivative":false,"issuer_cik":"0001195116","issuer_name":"Arno Therapeutics, Inc","issuer_ticker":"ARNI","issuer_name_source":null,"issuer_url":"/issuer/0001195116","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":714285.0,"shares_display":"714,285","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2262838.0,"shares_owned_after_display":"2,262,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider"},{"id":2502405,"accession":"0000914190-16-000517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914190-16-000517","line_url":"/filing/0000914190-16-000517","is_derivative":false,"issuer_cik":"0001195116","issuer_name":"Arno Therapeutics, Inc","issuer_ticker":"ARNI","issuer_name_source":null,"issuer_url":"/issuer/0001195116","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2162347.0,"shares_display":"2,162,347","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":756821.45,"total_display":"756,821.45","total_whole":"756,821","shares_owned_after":1548543.0,"shares_owned_after_display":"1,548,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-01-12","filed_date":"2016-01-14","scope":"insider","n_lines":2},{"id":4768043,"accession":"0000914190-13-000786","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000914190-13-000786","line_url":"/filing/0000914190-13-000786#line-7","is_derivative":false,"issuer_cik":"0001195116","issuer_name":"Arno Therapeutics, Inc","issuer_ticker":"ARNI","issuer_name_source":null,"issuer_url":"/issuer/0001195116","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":379294.0,"shares_owned_after_display":"379,294","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-11-05","scope":"insider"},{"id":4768040,"accession":"0000914190-13-000786","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000914190-13-000786","line_url":"/filing/0000914190-13-000786#line-6","is_derivative":false,"issuer_cik":"0001195116","issuer_name":"Arno Therapeutics, Inc","issuer_ticker":"ARNI","issuer_name_source":null,"issuer_url":"/issuer/0001195116","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":104166.0,"shares_display":"104,166","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":254887.0,"shares_owned_after_display":"254,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-11-05","scope":"insider"},{"id":4768035,"accession":"0000914190-13-000786","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000914190-13-000786","line_url":"/filing/0000914190-13-000786#line-5","is_derivative":false,"issuer_cik":"0001195116","issuer_name":"Arno Therapeutics, Inc","issuer_ticker":"ARNI","issuer_name_source":null,"issuer_url":"/issuer/0001195116","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":104166.0,"shares_display":"104,166","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":143809.0,"shares_owned_after_display":"143,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-11-05","scope":"insider"},{"id":4573551,"accession":"0000914190-13-000787","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000914190-13-000787","line_url":"/filing/0000914190-13-000787#line-5","is_derivative":false,"issuer_cik":"0001195116","issuer_name":"Arno Therapeutics, Inc","issuer_ticker":"ARNI","issuer_name_source":null,"issuer_url":"/issuer/0001195116","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":83332.0,"shares_display":"83,332","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":174644.0,"shares_owned_after_display":"174,644","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-11-05","scope":"insider"},{"id":9240914,"accession":"0001179110-08-005965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-08-005965","line_url":"/filing/0001179110-08-005965","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":26.9994,"price_display":"27.00","price_state":"stated","total_value":134997.0,"total_display":"134,997.00","total_whole":"134,997","shares_owned_after":64664.0,"shares_owned_after_display":"64,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-21","filed_date":"2008-03-14","scope":"insider","n_lines":2},{"id":2751256,"accession":"0001179110-08-004871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-08-004871","line_url":"/filing/0001179110-08-004871","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":26.9994,"price_display":"27.00","price_state":"stated","total_value":134997.0,"total_display":"134,997.00","total_whole":"134,997","shares_owned_after":64664.0,"shares_owned_after_display":"64,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-21","filed_date":"2008-03-03","scope":"insider","n_lines":2},{"id":7104090,"accession":"0001179110-07-023819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-023819","line_url":"/filing/0001179110-07-023819#line-1","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":30.5,"price_display":"30.50","price_state":"stated","total_value":457500.0,"total_display":"457,500.00","total_whole":"457,500","shares_owned_after":59664.0,"shares_owned_after_display":"59,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-18","filed_date":"2007-12-20","scope":"insider"},{"id":9240601,"accession":"0001179110-07-019310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-019310","line_url":"/filing/0001179110-07-019310#line-1","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3700.0,"shares_display":"3,700","price_per_share":23.9,"price_display":"23.90","price_state":"stated","total_value":88430.0,"total_display":"88,430.00","total_whole":"88,430","shares_owned_after":44664.0,"shares_owned_after_display":"44,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-18","filed_date":"2007-10-03","scope":"insider"},{"id":8133315,"accession":"0001179110-07-013411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-013411","line_url":"/filing/0001179110-07-013411#line-1","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3700.0,"shares_display":"3,700","price_per_share":23.9,"price_display":"23.90","price_state":"stated","total_value":88430.0,"total_display":"88,430.00","total_whole":"88,430","shares_owned_after":44664.0,"shares_owned_after_display":"44,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-18","filed_date":"2007-06-19","scope":"insider"},{"id":7164802,"accession":"0001179110-07-009702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-009702","line_url":"/filing/0001179110-07-009702#line-1","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7100.0,"shares_display":"7,100","price_per_share":21.1,"price_display":"21.10","price_state":"stated","total_value":149810.0,"total_display":"149,810.00","total_whole":"149,810","shares_owned_after":40964.0,"shares_owned_after_display":"40,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-08","filed_date":"2007-05-10","scope":"insider"},{"id":7207239,"accession":"0001179110-07-005738","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-07-005738","line_url":"/filing/0001179110-07-005738#line-5","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":18.55,"price_display":"18.55","price_state":"stated","total_value":18550.0,"total_display":"18,550.00","total_whole":"18,550","shares_owned_after":33864.0,"shares_owned_after_display":"33,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-27","filed_date":"2007-03-09","scope":"insider"},{"id":7207237,"accession":"0001179110-07-005738","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-07-005738","line_url":"/filing/0001179110-07-005738","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":"0001296549","owner_name":"Belldegrun Arie","owner_display_name":"Belldegrun Arie","owner_url":"/insider/0001296549","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":18.31607142857143,"price_display":"18.32","price_state":"stated","total_value":256425.0,"total_display":"256,425.00","total_whole":"256,425","shares_owned_after":32364.0,"shares_owned_after_display":"32,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-26","filed_date":"2007-03-09","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":27,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001691082","name":"LB PHARMACEUTICALS INC","url":"/issuer/0001691082","role":"Ten percent owner","n_filings":1,"first_seen":"2025-09-16","last_seen":"2025-09-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001737287","name":"Allogene Therapeutics, Inc.","url":"/issuer/0001737287","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2018-10-17","last_seen":"2024-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001510580","name":"Kite Pharma, Inc.","url":"/issuer/0001510580","role":"Director, Officer (Chairman, President and CEO)","n_filings":3,"first_seen":"2016-12-22","last_seen":"2017-09-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001195116","name":"Arno Therapeutics, Inc","url":"/issuer/0001195116","role":"Director","n_filings":4,"first_seen":"2013-11-05","last_seen":"2016-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001335102","name":"Cougar Biotechnology, Inc.","url":"/issuer/0001335102","role":"Director","n_filings":7,"first_seen":"2007-03-09","last_seen":"2008-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001296549","retrieved_at":"2026-08-22T23:23:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}